Humacyte Inc.

1.46
-0.25 (-14.37%)
At close: Apr 01, 2025, 3:59 PM

Humacyte Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue n/a n/a 1.56M 1.26M 1.49M
Cost of Revenue n/a 76.55M 8.26M 49K 8.43M
Gross Profit n/a -76.55M -6.69M 1.21M -6.94M
Operating Income -114.4M -100.05M -84.58M -81.21M -64.6M
Interest Income 4.1M n/a 2.63M 16K 278K
Pretax Income n/a -110.78M -11.96M -26.48M -66.52M
Net Income n/a -110.78M 64.22M 37.54M -68.73M
Selling & General & Admin 25.8M 20.39M 22.88M 21.13M 12.01M
Research & Development 88.6M 76.55M 63.26M 61.34M 54.08M
Other Expenses n/a -73.44M -1.56M -1.26M -1.49M
Operating Expenses 114.4M 23.5M 84.58M 81.21M 64.6M
Interest Expense -9.28M 1.13M 6.2M 4.35M 2.2M
Selling & Marketing Expenses n/a -3M n/a n/a n/a
Cost & Expenses n/a 100.05M 84.58M 81.21M 64.6M
Income Tax n/a n/a -76.18M -64.01M 2.2M
Shares Outstanding (Basic) 118.48B 103.42M 103.05M 39.97M 12.45M
Shares Outstanding (Diluted) 118.48B 103.42M 103.05M 39.97M 12.45M
EPS (Basic) -1.26 -1.07 0.62 0.94 -5.52
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -114.4M -96.46M 2.49M -72.97M -56.25M
Depreciation & Amortization n/a 7.72M 8.26M 8.28M 8.43M